Relationship between carnitine, fatty acids and insulin resistance

Author(s): Lohninger A, Radler U, Jinniate S, Lohninger S, Karlic H, et al.

Abstract

Increased plasma free fatty acid (FFA) levels are a feature of insulin resistance and type 2 diabetes. The aim of the present study was to assess the effect of L-carnitine supplementation on plasma lipids and the expression of enzymes in peripheral mononucleated cells (PMNC) involved in the regulation of fatty acid and glucose oxidation. L-Carnitine supplementation of 2 g/day resulted in a significant decrease in plasma FFA and in a less pronounced diminution of the plasma triacylglycerols. In addition, a concomitant increase in the relative mRNA abundances of carnitine acyltransferases (5- to 10-fold) and of the carnitine carrier OCTN2 (12-fold) in PMNC of pregnant women was found. The results of the present study provide evidence that L-carnitine supplementation in pregnancy (2 g/day) avoids a striking increase in plasma FFA, which are thought to be the main cause of insulin resistance and consequently gestational diabetes mellitus.

Similar Articles

Membranes as possible pacemakers of metabolism

Author(s): Hulbert AJ, Else PL

Life, death and membrane bilayers

Author(s): Hulbert AJ

Quantitative atomic force microscopy with carbon monoxide terminated tips

Author(s): Sun Z, Boneschanscher MP, Swart I, Vanmaekelbergh D, Liljeroth P

Structure of lipid bilayers

Author(s): Nagle JF, Tristram-Nagle S

The cellular fate of glucose and its relevance in type 2 diabetes

Author(s): Bouché C, Serdy S, Kahn CR, Goldfine AB

Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes

Author(s): Kelley DE, He J, Menshikova EV, Ritov VB

Is irisin a human exercise gene? Nature 488: E9-10

Author(s): Timmons JA, Baar K, Davidsen PK, Atherton PJ

FNDC5 and irisin in humans: I

Author(s): Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, et al.

MR properties of brown and white adipose tissues

Author(s): Hamilton G, Smith DL Jr, Bydder M, Nayak KS, Hu HH

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

Author(s): Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, et al.

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

Author(s): Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al.

Hemorheological disorders in diabetes mellitus

Author(s): Cho YI, Mooney MP, Cho DJ

Modulation of the bilayer thickness of exocytic pathway membranes by membrane proteins rather than cholesterol

Author(s): Mitra K, Ubarretxena-Belandia I, Taguchi T, Warren G, Engelman DM